Literature DB >> 11754815

CD28 as a molecular amplifier extending TCR ligation and signaling capabilities.

F Michel1, G Attal-Bonnefoy, G Mangino, S Mise-Omata, O Acuto.   

Abstract

Evidence has gathered that CD28 costimulation facilitates T cell activation by potentiating TCR intrinsic-signaling. However, the underlying molecular mechanism is largely unknown. Here we show that, by enhancing T cell/APC close contacts, CD28 facilitates TCR signal transduction. Moreover, the signal supplied by CD28 does not lead to increased Zap-70 and Lat phosphorylation, but amplifies PLCgamma1 activation and Ca(2+) response. We provide evidence that the PTK Itk controls the latter function. Our data suggest that CD28 binding to B7 contributes to setting the level of TCR-induced phosphorylated Lat for recruiting signaling complexes, whereas the CD28 signal boosts multiple pathways by facilitating PLCgamma1 activation. These results should provide a conceptual framework for understanding quantitative and qualitative aspects of CD28-mediated costimulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754815     DOI: 10.1016/s1074-7613(01)00244-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  60 in total

1.  Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation.

Authors:  Maximilian Diehn; Ash A Alizadeh; Oliver J Rando; Chih Long Liu; Kryn Stankunas; David Botstein; Gerald R Crabtree; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

2.  In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation.

Authors:  Stéphanie O Morin; Valentin Giroux; Cédric Favre; Yassina Bechah; Nathalie Auphan-Anezin; Romain Roncagalli; Jean-Louis Mège; Daniel Olive; Marie Malissen; Jacques A Nunès
Journal:  Cell Mol Life Sci       Date:  2015-03-01       Impact factor: 9.261

Review 3.  Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy.

Authors:  Kushal Prajapati; Cynthia Perez; Lourdes Beatriz Plaza Rojas; Brianna Burke; Jose A Guevara-Patino
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

4.  The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation.

Authors:  Suhnrita Chaudhuri; Manoj Kumar Singh; Debanjan Bhattacharya; Sagar Acharya; Sirshendu Chatterjee; Pankaj Kumar; Pushpak Bhattacharjee; Anjan Kumar Basu; Gaurisankar Sa; Tanya Das; Tushar Kanti Ghosh; Swapna Chaudhuri
Journal:  J Neurooncol       Date:  2014-07-16       Impact factor: 4.130

5.  CD28 co-signaling in the adaptive immune response.

Authors:  Pavel Riha; Christopher E Rudd
Journal:  Self Nonself       Date:  2010-07-12

6.  Cutting edge: A double-mutant knockin of the CD28 YMNM and PYAP motifs reveals a critical role for the YMNM motif in regulation of T cell proliferation and Bcl-xL expression.

Authors:  Jonathan S Boomer; Christine M Deppong; Dulari D Shah; Traci L Bricker; Jonathan M Green
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

7.  CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters.

Authors:  Barbara Marinari; Antonio Costanzo; Valeria Marzano; Enza Piccolella; Loretta Tuosto
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

8.  Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.

Authors:  Sarah R Jacobs; Catherine E Herman; Nancie J Maciver; Jessica A Wofford; Heather L Wieman; Jeremy J Hammen; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

9.  Dok-4 is a novel negative regulator of T cell activation.

Authors:  Audrey Gérard; Marguerite Ghiotto; Camille Fos; Geoffrey Guittard; Daniel Compagno; Anne Galy; Serge Lemay; Daniel Olive; Jacques A Nunès
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

10.  Transmembrane adaptor proteins positively regulating the activation of lymphocytes.

Authors:  Inyoung Park; Yungdae Yun
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.